|
Re: What impact would a PR like this have?
|
6
|
Resverlogix Corp.
|
Jan 28, 2019 11:33PM
|
|
Re: Phase 4 - Appraently for drugs already approved for marketing.....
|
2
|
Resverlogix Corp.
|
Jan 28, 2019 07:52AM
|
|
Re: Phase 4 - Appraently for drugs already approved for marketing.....
|
4
|
Resverlogix Corp.
|
Jan 27, 2019 11:06PM
|
|
Re: Interesting paper on BET inhibitors and Memory
|
4
|
Resverlogix Corp.
|
Jan 27, 2019 09:39PM
|
|
Re: Interesting Trades / Volume .....
|
4
|
Resverlogix Corp.
|
Jan 27, 2019 09:08PM
|
|
Interesting paper on BET inhibitors and Memory
|
5
|
Resverlogix Corp.
|
Jan 27, 2019 06:03PM
|
|
Re: Interesting Trades / Volume .....
|
5
|
Resverlogix Corp.
|
Jan 26, 2019 10:53PM
|
|
Re: Interesting Trades / Volume .....
|
4
|
Resverlogix Corp.
|
Jan 26, 2019 09:50PM
|
|
Re: Interesting Trades / Volume .....
|
3
|
Resverlogix Corp.
|
Jan 26, 2019 09:19PM
|
|
Re: The final events.....
|
5
|
Resverlogix Corp.
|
Jan 26, 2019 04:23PM
|
|
Re: Interesting Trades / Volume .....
|
6
|
Resverlogix Corp.
|
Jan 25, 2019 06:09PM
|
|
Re: Confrimed versus Suspected MACE...
|
4
|
Resverlogix Corp.
|
Jan 25, 2019 01:20PM
|
|
Re: The final events.....
|
4
|
Resverlogix Corp.
|
Jan 25, 2019 11:59AM
|
|
Re: The final events.....
|
2
|
Resverlogix Corp.
|
Jan 25, 2019 11:38AM
|
|
Re: The final events.....
|
2
|
Resverlogix Corp.
|
Jan 25, 2019 11:11AM
|
|
The final events.....
|
6
|
Resverlogix Corp.
|
Jan 25, 2019 10:48AM
|
|
Re: 250 MACE scenario question
|
4
|
Resverlogix Corp.
|
Jan 24, 2019 09:31PM
|
|
Re: 250 MACE scenario question
|
6
|
Resverlogix Corp.
|
Jan 24, 2019 07:44PM
|
|
Re: Secondary indications
|
5
|
Resverlogix Corp.
|
Jan 24, 2019 12:43PM
|
|
3 Resverlogix trials recently updated on ClinicalTrials.gov
|
7
|
Resverlogix Corp.
|
Jan 24, 2019 12:07PM
|
